Respiratory Journals &IFs

It is widely recognised that one of the most important and difficult parts of the publishing process is the selection of the appropriate journal. This generally means the journal with the highest impact factor/ impact which would accept your article (and would charge you a reasonable fee). Undoubtedly, the higher the impact factor of a journal, the most appreciated it is and the widest audience it reaches.

Another important factor for both the journal and the author is how relevant is the topic of the article to the journal's topics/interests. Generally, it is easier for a paper to be accepted by a more specialised journal (than a less specialised with the same impact factor) and it would reach a more confined audience but also a larger proportion of the scientists of the same areas of interest.

It needs some experience in order to estimate the appropriate impact factor and the precise prediction of the outcome is definitely impossible.

Many authors prefer to try to submit their papers in journals with higher impact factors than the "ideal" for their papers for three reasons: 1. There is always a possibility of being accepted. 2. The reviewers' comments would help the subsequent submission. 3. The worst case scenario is a 2-month delay of the publication.

Here we have collected all the Respiratory Journals, along with their impact factors and their preferred subjects, according to their editors.

 

 

 

--------------------------

 

IF = Impact Factor

 

--------------------------

American Journal of Respiratory and Critical Care Medicine (Am J Respir Crit Care Med, IF = 10.191)

The American Journal of Respiratory and Critical Care Medicine publishes original papers on human biology and disease, as well as animal and in vitro studies, which contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients. Only papers written in English can be considered. Manuscripts should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org). The Journal is published in both print and electronic formats and may be viewed online at http://www.atsjournals.org/ or at http://intl.atsjournals.org/. Articles in Press (articles posted on the Journal's website before the print version) may be viewed online at http://ajrccm.atsjournals.org/content/early/recent.

SUBMISSION FEES (before acceptance): Authors are billed a $50.00 submission fee at the time of the submission of a manuscript. Submission fees are nonrefundable. Please write to the Publisher if there is a hardship or special circumstances.

PAGE CHARGES (after acceptance): Authors are billed for page charges at different rates depending on their ATS membership status. Nonmembers are billed at the rate of $100 per printed page. Full U.S. ATS members and international Level A members are billed $70,  U.S. affiliate members are billed $80, U.S. and international trainee members are billed $40, international Level B members are billed $45, and international Level C members are billed $20 per printed page. Member discounts are based solely on the corresponding author’s membership status in the Society. Level B and C memberships comprise countries with limited resources. (If you are not a member of the ATS and would like to join, please visit the “Become a Member” page, or contact membership@thoracic.org or 212-315-8685.)

 

The Journal of Allergy and Clinical Immunology (J Allergy Clin Immunol, IF: 9.273

No fees

 

Chest (IF - 6.519)

Fee: Beginning with the July 2009 issue, CHEST will adjust its access restriction policy to facilitate compliance with the Wellcome Trust (and other relevant funding bodies) requirement for authors to deposit papers in an open-access repository. For Wellcome-funded authors whose papers are accepted and published in CHEST, the journal requires an open access fee of $3000. Upon payment of the fee, CHEST will deposit the Wellcome Trust-funded article into PubMed Central and ensure immediate free and open access of the article on the CHEST online journal (http://chestjournal.chestpubs.org) and on PubMed.

 

Thorax (IF - 6.252)

Thorax seeks to publish significant advances in scientific understanding which are likely to impact on clinical practice. Articles concerning clinical topics, critical care, and those on basic mechanisms with application to clinical material, will be welcomed. We aim to cover all areas of respiratory medicine (epidemiology, paediatrics, immunology, sleep, pharmacology, pathology, surgery and critical care) through publishing original papers, editorials, reviews, case based discussions and images. The priorities are originality and excellence. All submissions are subject to peer review. All papers that are potentially acceptable undergo statistical analysis.

Submissions to Thorax if favorably peer reviewed, are discussed at the weekly editorial committee prior to decision. We aim to ensure a fair and independent peer review system and to publish articles which follow the highest ethical standards concerning research conduct.

Fees: During submission you will be asked whether or not you agree to pay for the colour print publication of your colour images. This service is available to any author publishing within this journal for a fee of £250 per article. Authors can elect to publish online in colour and black and white in print, in which case the appropriate selection should be made upon submission.

 

European Respiratory Journal (Eur Respir J, IF - 5.992)

The European Respiratory Journal (ERJ), the official journal of the European Respiratory Society (ERS), publishes 12 issues per year in English.

The ERJ publishes clinical and experimental work dealing with the whole field of respiratory medicine, including cell biology, epidemiology, immunology, pathophysiology, thoracic imaging, paediatric pneumology, occupational medicine, intensive care, sleep medicine, thoracic surgery and thoracic oncology. In addition to such original material, the ERJ prints Editorials, Reviews, Technical Notes, Correspondence and Letters to the Editor.

The ERJ takes part in the HINARI Programme. The HINARI Programme, set up by the World Health Organization (WHO) together with major publishers, enables developing countries to gain access to collections of biomedical and health literature. Over 6,400 journal titles are now available to health institutions in 108 countries, areas and territories benefiting many thousands of health workers and researchers, and in turn, contributing to improved world health. For more information about HINARI, go to www.who.int/hinari/en/. The European Respiratory Society is a member of the Committee on Publication Ethics (COPE), and follows COPE's codes of conduct and best practice guidelines.

Fees: There is a flat fee of £2,000. Payment in GBP is preferred, although other currencies may be permissible subject to contacting our accounts department. The article charge does not cover any extra costs associated with publication, e.g. colour charges, about which you would be notified if your article is selected for publication. You will be required to complete and submit an Article Charge Form (link to form). You will need to complete all requested details. As the authors or nominated corresponding author, you are responsible for the payment of this fee. Pre-payment in full is required to activate ERJ Open. If ERS does not receive payment of the fees, it reserves the right to reverse the process to make it open access.

 

Journal of Thoracic Oncology (J Thorac Oncol, IF: 4.547)

Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.

No fees

 

American Journal of Respiratory Cell and Molecular Biology (Am J Respir Cell Mol Biol, IF - 4.426)

The American Journal of Respiratory Cell and Molecular Biology focuses on papers that use cellular, biochemical, developmental, genetic, immunologic, and molecular approaches to understand structure and function of the respiratory system under physiologic and pathophysiologic conditions. Acceptance of manuscripts is based on scientific excellence, significance, and clarity of presentation. The Journal also publishes Editorials and state-of-the-art Translational Reviews. Translational Reviews are initiated by submitting authors, but consultation with the Editor (kenneth_adler@ncsu.edu) before submission is recommended.

Submission Fees (before acceptance)

Authors are billed a $50 submission fee at the time of the submission of a manuscript. Submission fees are not refundable. Please write to the Publisher if there is a hardship or special circumstances.

Page Charges (after acceptance)

Authors are billed for page charges at different rates depending on their ATS membership status. Nonmembers are billed at the rate of $100 per printed page. Full U.S. ATS members and international Level A members are billed $70, U.S. affiliate members are billed $80, U.S. and international trainee members are billed $40, international Level B members are billed $45, and international Level C members are billed $20 per printed page. Member discounts are based solely on the corresponding author’s membership status in the Society. Level B and C memberships comprise countries with limited resources. (If you are not a member of the ATS and would like to join, please visit the “Become a Member” page, or contact membership@thoracic.org or 212-315-8685.)

 

American Journal of Physiology - Lung Cellular and Molecular Physiology (Am J Physiol Lung Cell Mol Physiol, IF: 4.137)

The American Physiological Society (APS) Journals seek definitive papers that present the entire contents of a research project. In general, all data from a group of subjects, animals, or samples should be presented together in a single paper. If this cannot be done, then the manuscript should be cross-referenced. Identical subject, animal, and sample numbers should be used in the different manuscripts to identify their commonality.

Mandatory Submission Fee: There is a one-time Mandatory Submission Fee of $50 for each article submitted to most of the APS Journals. This fee is nonrefundable. Only authors of reviews, editorials, and letters, as well as those submitting to Advances in Physiology Education do not have to pay this fee.

Page Charges: To recover part of publication costs, the APS charges authors of research articles $75 per final-published PDF page. By signing the Mandatory Submission Form, the author agrees to pay page charges once his/her paper is published. (Forms customized to your manuscript will become available on completion of the submission process; check the Info Page of the journal you are submitting to for blank forms.) Excessive changes made in proof will be subject to additional charges.

The page charges are waived for authors of reviews, editorials, and letters and for those publishing in Physiological Reviews, Physiology, and Advances in Physiology Education.

Cost of Color: We will publish scientifically necessary color figures free of charge if the first or the last author is an APS member in good standing (this includes student members).

Please submit in color only if you intend for the figure(s) to be published in color. Unnecessary color figures are not permitted in the Journals, and in such cases authors will be required to provide a black and white version suitable for publication. The APS Publications Department is the final arbiter of whether color for a figure is scientifically necessary.

Nonmembers will be charged the low subsidized rate of $400 per color figure. APS will not delay publication of any article for the sake of a pending membership application; membership status will be assessed at the time the color fee is due.

Color is free for authors publishing in Physiological Reviews, Physiological Genomics, and Physiology. If your article has color figures, there is an additional press charge of $100 per 100 reprints ordered.

Toll-free link: at your request, the APS can create a link from your online published article to a URL you specify. Readers accessing your article from this URL can do so without a subscription to the journal. The per-article cost is $150 ($250 for articles in Physiological Reviews) and can be noted on the Reprint Order Form. Payment for the link will be added to the invoice for publication fees.

 

Influenza and Other Respiratory Viruses (Influenza Other Respi Viruses, IF: 3.812)

Open article fee: OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see

 

The Journal of Thoracic and Cardiovascular Surgery (J Thorac Cardiovasc Surg, IF: 3.608)

The Editors of The Journal of Thoracic and Cardiovascular Surgery aim to promote excellence in the discipline and educate those practicing and interested in our specialty. To this end, the Journal accepts submissions in the form of original articles, brief communications, editorials, and letters to the Editor on topics pertaining to the most recent developments in cardiothoracic transplantation, general thoracic surgery, surgery for acquired and congenital cardiovascular disease, and technical and physiologic issues as they relate to the specialty. The Journal commits to rigorous peer review, freedom from commercial influence, and promotion of the highest ethical and scientific standards in our specialty.

No fees.

 

The Annals of Thoracic Surgery (Ann Thorac Surg, IF: 3.558)

The Annals of Thoracic Surgery publishes original articles on topics in thoracic and cardiovascular surgery and features such as case reports, "how to do it" articles, image reports, new technology evaluations, STS workforce reports, review articles, articles on our surgical heritage, book reviews, invited editorials, correspondence, commentary and four Continuing Medical Education (CME) activities each month. The electronic issue of the journal posted on CTSNet (http://ats.ctsnetjournals.org) is the journal of record.

No fees.

 

The Journal of Heart and Lung Transplantation (J Heart Lung Transplant, IF: 3.541)

The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy; Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas

No fees.

 

 

Journal of Sleep Research (J Sleep Res, IF: 3.361)

Open article fee: OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.

 

Lung Cancer (Lung Cancer, IF: 3.356)

Lung Cancer aims to provide individuals or organisations with the most recent information on lung cancer and other thoracic malignancies. The Journal publishes original research articles, early reports, review articles and editorials on clinical and basic science aspects of topics represented by the fields of interest of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities, outcomes). Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review. Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

No fees.

 

Current Opinion in Pulmonary Medicine (Curr Opin Pulm Med, IF: 2.906)

Current Opinion in Pulmonary Medicine publishes invited articles only. We are unable to consider unsolicited manuscripts for publication.

 

Pediatric Allergy and Immunology (Pediatr Allergy Immunol, IF: 2.874)

Fees: John Wiley & Sons, Inc. offers authors the option of making their article available to non-subscribers in a selection of journals on Wiley Online Library. The prepaid charge for this service is $3,000, payable only in US Dollars. Authors who have had an article accepted after July 2006, and who wish to exercise this option should complete and submit this form. For additional information on Wiley's OnlineOpen service, please contact us.

 

Respiratory Research (Respir Res, IF: 2.86)

Respiratory Research is an open access journal aiming at publishing high-quality science in all areas of respiratory disease. Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems. The journal accepts submission relating to both clinical and basic research in the respiratory field. The journal also welcomes state-of-the-art reviews on any topic related to the scope of the journal.

Fees: An article processing charge of £1495/US$2320/€1840 is payable for articles accepted for publication in Respiratory Research. If your institution, society or other organization is a member, this cost may be wholly or partly covered by the membership arrangement. Article processing charge waivers or discounts are granted on a case-by-case basis to authors who lack funds. To apply for a waiver or discount, please request one during the submission process. A decision on the waiver will normally be made within two working days. Submission of the article to the journal can be completed once the payment method has been agreed. Any applicable article processing charge must be paid prior to publication.

 

Journal of Cystic Fibrosis (J Cyst Fibros, IF: 2.840)

Journal of Cystic Fibrosis publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis and is published four times a year. Accepted papers become the copyright of the Journal and are accepted on the understanding that they have not been published, and are not being considered for publication elsewhere and are subject to editorial revision.

No fees.

 

Annals of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol, IF: 2.801)

The Annals of Allergy, Asthma & Immunology is the official journal of the  American College of Allergy, Asthma and Immunology. The Annals acceptance rate is approximately 32%. Median turnaround time from submission to first decision 22 days, from submission to acceptance is 78 days, and acceptance to publication is 86 days.

Editor-in-Chief: Gailen D. Marshall, MD PhD

Deputy Editor: Mitchell H. Grayson, MD

Managing Editor: Kimberly K. Stamper, PMP

No fees.

 

Nicotine & Tobacco Research (Nicotine Tob Res, IF: 2.801)

The journal of Nicotine & Tobacco Research is the official journal for the Society for Nicotine & Tobacco Research. The papers in the journal focus primarily on the neurobiology, psychology, epidemiology, and issues concerned with tobacco policy and public health related to tobacco use and dependence. The journal also focuses on clinical aspects of the subject particularly with regard to interventions employed in tobacco cessation.

Open access fees: Nicotine and Tobacco Research authors have the option to publish their paper under the Oxford Open initiative; whereby, for a charge, their paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to accept a mandatory license to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged. 

 

Paediatric Respiratory Reviews (Paediatr Respir Rev, IF: 2.676)

No fees,

 

Tuberculosis (Tuberculosis, IF: 2.650)

No fees,

 

International Journal of Tuberculosis & Lung Disease (Int J Tuberc Lung Dis, IF: 2.557)

The IJTLD is the reference for clinical research and epidemiological studies on tuberculosis. It is also the only peer-reviewed journal dedicated to lung health worldwide, including articles on TB-HIV and non tuberculosis related respiratory diseases such as asthma, acute respiratory infection, COPD, child lung health and the hazards of tobacco and pollution.

The IJTLD publishes original articles and commissioned reviews on the clinical and biological aspects of pneumology, and on community aspects. With its emphasis on lung health in developing countries, the IJTLD encourages submissions that incorporate: fundamental research, the elaboration, implementation and assessment of field projects and action programmes for tuberculosis control and the promotion of lung health.

The IJTLD welcomes articles on all aspects of lung health, including public health related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research.

No fees.

 

Respiration (Respiration, IF: 2.543)

There are no page charges for papers of 4 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.00. The allotted size of a paper is equal to approx. 12 manuscript pages (including tables, illustrations and references).

 

Respiratory Medicine (Respir Med, IF: 2.525)

Respiratory Medicine is an internationally-renowned, clinically-oriented journal, combining cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions, but with a clear clinical relevance. The journal is an established forum for the publication of phased clinical trial work at the forefront of interventive research. As well as full-length original research papers, the journal publishes reviews, correspondence, and short reports. The Journal also publishes regular supplements on areas of special interest.

No fees.

 

Seminars in Respiratory and Critical Care Medicine (Semin Respir Crit Care Med, IF: 2.492)

No fees.

 

Respirology (Respirology, IF: 2.416)

Respirology is the official journal of the Asian Pacific Society of Respirology. It is the preferred English language journal of the Japanese Respiratory Society, the Thoracic Society of Australia and New Zealand and the Taiwanese Society of Pulmonary and Critical Care Medicine, and an official journal of the World Association of Bronchology and Interventional Pulmonology. The Journal publishes original papers of international interest on laboratory and clinical research that are pertinent to respiratory biology and disease. Manuscripts on any topic within the field of respiratory medicine, including allied health; cell and molecular biology; epidemiology; immunology; pathology; pharmacology; physiology; intensive and critical care; paediatric respiratory medicine; bronchoscopy; interventional pulmonology and thoracic surgery are welcomed.

Fees: After acceptance of the manuscript, the corresponding author (as listed on the title page of the manuscript) will be charged a publication fee. Authors must agree to pay the fee upon submission of their manuscript and payment must be finalised prior to the manuscript being published. Correspondences and Invited papers are excluded from this fee. Depending on the GDP per capita of the corresponding author's country of residence, the fee is US$300, US$150 or US$50 per manuscript. Please refer to the following website for the publication fee per country; http://www.blackwellpublishing.com/pdf/res_pubfee.pdf. Authors should contact the Editorial Office (respirology-aphb@uwa.edu.au) in case of hardship or special circumstance.

 

Clinical Lung Cancer (Clin Lung Cancer, IF: 2.362)

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

No fees.

 

Current Allergy and Asthma Reports (Curr Allergy Asthma Rep, IF: 2.346)

No fees.

 

Respiratory Physiology & Neurobiology (Respir Physiol Neurobiol, IF: 2.325)

Respiratory Physiology & Neurobiology publishes original articles and invited reviews concerning the field of respiration in its broadest sense. Although a special focus is on topics in neurobiology, high quality papers in respiratory molecular and cellular biology are also welcome, as are high quality papers in traditional areas, such as mechanics of breathing; gas exchange in lungs, gills, skin, and tissues; acid-base balance; respiration at rest and exercise; respiration in normal and unusual conditions, like high or low pressure or changes of temperature, low ambient oxygen; embryonic and adult respiration; comparative respiratory physiology. Papers on clinical aspects, articles on original methods, as well as theoretical papers are also considered as long as they foster the understanding of respiratory physiology.

Open access fees only: This journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies have entered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at http://www.elsevier.com/fundingbodies. Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at http://www.elsevier.com/locate/openaccessform.pdf). Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. 

 

Clinics in Chest Medicine (Clin Chest Med: 2.311)

The Clinics publishes current review articles covering topics of use in daily practice and for in-depth comprehension. Topics span the breadth and depth of synthesized information on a subject – evidence-based information provides the practitioner with medical information useable for point-of-care as well as for further comprehension and analysis.

No fees.

 

Inhalation Toxicology (Inhal Toxicol, IF: 2.295)

nhalation Toxicology is a peer-reviewed monthly publication providing a key forum for the latest accomplishments and advancements in concepts, approaches, and procedures presently being used to evaluate the health risk associated with airborne chemicals. The journal publishes original research, reviews, symposia, and workshop topics involving the respiratory system‟s functions in health and disease, the pathogenesis and mechanism of injury, the extrapolation of animal data to humans, the effects of inhaled substances on extra- pulmonary systems, as well as reliable and innovative models for predicting human disease.

Color figure fees only: Any figure submitted as a color original will appear in color in the Journal‟s online edition free of charge. Print copy color reproduction will only be considered on condition that authors bear the associated costs. The charge for the first page with color is US $1000/£500, each subsequent page is charged at US $500/£250. There are no charges for non-color pages.

 

European Journal of Cardio-Thoracic Surgery (Eur J Cardiothorac Surg, IF: 2.293)

The European Journal of Cardio-Thoracic Surgery (EJCTS) welcomes scientific contributions to the journal in the field of cardio-thoracic surgery. All manuscripts are subject to review by the Editor, Associate Editors, Invited Referees and a Statistician when appropriate. Acceptance is based on the originality, significance, and validity of the material presented. 

Open Access fees only.

 

COPD: Journal of Chronic Obstructive Pulmonary Disease (COPD, IF: 2.250)

From pathophysiology and cell biology to pharmacology and psychosocial impact, COPD: Journal Of Chronic Obstructive Pulmonary Disease publishes a wide range of original research, reviews, case studies, and conference proceedings to promote advances in the pathophysiology, diagnosis, management, and control of lung and airway disease and inflammation - providing a unique forum for the discussion, design, and evaluation of more efficient and effective strategies in patient care.

iOpenAccess fees only: Articles in COPD : Journal of Chronic Obstructive Pulmonary Disease are eligible for non-commercial purchase via iOpenAccess. Electing this option allows the article to be made freely available online under a Creative Commons License. The iOpenAccess service requires registration with Rightslink, and payment of a one-time fee of $3250. Authors of accepted papers will have the opportunity to purchase iOpen Access at proofs stage. For further information about iOpenAccess, please contact the publisher. Please note: This option is separate from Informa Healthcare’s NIH/Wellcome Fund policy.

 

Pediatric Pulmonology (Pediatr Pulmonol, IF: 2.239)

Pediatric Pulmonology publishes state of the art reviews, editorials, the results of original clinical or laboratory research, exceptionally instructive or unique case reports, and letters to the Editor pertaining to pediatric pulmonology. Reports on meetings, conferences and symposia may be published after consultation with the Publisher and the Editor-in-Chief. Preliminary brief communications will be considered only if they contain information that can be considered a major breakthrough. The length of original articles is not limited but the author(s) should be aware that very long manuscripts are more difficult to publish owing to space limitations, case reports should be concise ( a maximum of 3 typewritten pages excluding references) and contain a maximum of two figures and or tables. Authorship of case reports shall be limited to three unless the role of each co-author is carefully justified in a separate letter to the editor. The Editors reserve the right to return any manuscript that is not in acceptable English. Translations from another language will not be provided by the Editorial Office. Note that in accord with other leading respiratory journals, we do not publish research funded by tobacco companies.

Color figure fees only. Printing costs of color illustrations will be charged to the author. The Editor-in-Chief has the discretion to wave the color charges.

 

Archivos de Bronconeumologia (Arch Bronconeumol, IF: 2.170)

ARCHIVOS DE BRONCONEUMOLOGÍA gives preference to studies related to respiratory health, whether medical, surgical, or experimental.

No fees.

 

Journal of Aerosol Medicine and Pulmonary Drug Delivery (J Aerosol Med Pulm Drug Deliv, IF: 2.148)

No fees.

 

Primary Care Respiratory Journal (Prim Care Respir J, IF: 2.11)

The Primary Care Respiratory Journal (PCRJ) is an open access, fully- indexed, international academic journal relevant to anyone with an interest in the primary care management of respiratory and respiratory- related allergic diseases. It is the official journal of the Primary Care Respiratory Society UK (PCRS-UK) and the International Primary Care Respiratory Group (IPCRG). The Journal publishes research papers, clinical reviews, discussion papers, editorials, letters and correspondence relating to all aspects of respiratory and respiratory-related allergic conditions. It also publishes news and articles concerning the policies and activities of the PCRS-UK, IPCRG, and related organisations worldwide.

No fees.

 

Pulmonary Pharmacology and Therapeutics (Pulm Pharm Ther, IF: 2.093)

Pulmonary Pharmacology & Therapeutics is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung (including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema) and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.

No fees.

 

BMC Pulmonary Medicine (BMC Pulm Med, IF: 1.91)

BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Fees: Open access publishing is not without costs. BMC Pulmonary Medicine therefore levies an article-processing charge of £1230/$1910/€1515 for each article accepted for publication.  We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page.

 

Journal of Breath Research (J Breath Res, IF: 1.828)

Colour figure fees only: The use of colour in figures can enhance the effective presentation of results, and there are no restrictions on the use of colour in the online version of your article. However, because conventional full-colour printing remains an expensive process, we must ask you (or your institution) to pay the additional costs incurred (i.e. the costs over and above the cost of normal black-on-white reproduction) if you also require colour in the printed version of your article. An estimate of the charges for your article can be obtained from the Publishing Administrator of the journal.

 

Allergy and Asthma Proceedings (Allergy Asthma Proc, IF: 1.735)

Fees: Submission for content review (only): $50. This fee applies to all submitted abstracts, regardless of whether the author is requesting publication.

Submission for Publication: $300 for supported work; $0 for unsupported work (RSL Allergy Society members). Authors have the options for their abstracts to be published in an upcoming issue of the journal, Allergy & Asthma Proceedings. The fee for the publication of supported abstracts is faxed (401) 331-0223, or emailed (susancolucci@oceansidepubl.com) to the Editorial office at the time of submission. Of note, because of possible copyright infringements, abstracts which have been submitted for publication elsewhere will not be published inAllergy & Asthma Proceedings.

 

Lung (Lung, IF: 1.734)

The journal accepts the following types of papers: original article, original research, state of the art review, brief report, editorial, book review, and lung images.

No fees.

 

Sleep and Breath (Sleep Breath, IF: 1.684)

No fees.

Annals of Thoracic Medicine (Ann Thorac Med, IF: 1.617)

The journal does not charge for submission, processing or publication of manuscripts and even for color reproduction of photographs. 

 

Sarcoidosis Vasculitis and Diffuse Lung Diseases (Sarcoidosis Vasc Diffuse Lung Dis, IF: 1.541)

The Sarcoidosis Vasculitis and Diffuse Lung Diseases will publish original research that addresses prevalence, causes, mechanisms, diagnosis, course, treatment or prevention of sarcoidosis, vasculitis, and interstitial lung diseases. We will consider various study types, including original research, meta-analyses and cost-effectiveness analyses.We divide original research into two categories: Original Articles (3200 or fewer words) and Brief Communications (1500 or fewer words). Brief Communications usually address preliminary or limited results of original research, including case series and important case reports of new treatments or serious adverse events. We will consider both narrative and systematic reviews.Narrative reviews are especially suitable for describing cutting-edge and evolving developments, and discussing those developments in light of underlying theory. Systematic reviews are especially suitable for critiquing and summarizing a body of evidence relevant to focused questions about diagnostic, prognostic, or therapeutic clinical practices. For narrative reviews, we ask that authors include a box listing three to seven take-home points that link back to the original questions that the review set out to answer. Prior to preparing a review, we recommend contact one of the Editors regarding the potential for publication in the Journal. The editors may also solicit specific reviews from leaders in the field.

No fees.

 

Clinical and Molecular Allergy (Clin Mol Allergy, IF: 1.52) 

Clinical and Molecular Allergy publishes research on all clinical and molecular aspects of allergic (Type 1 hypersensitivity) and primary immunodeficiency disorders (diseases that alter host defense but are not related to Human Immunodeficiency Virus infection). Studies of allergic or hypersensitive aspects of HIV infection/AIDS or drug desensitization protocols in AIDS, however, fall into the journal’s scope.

No fees.

 

Respiratory Care (Resp Care, IF: 1.534)

RESPIRATORY CARE welcomes original manuscripts related to the science, technology, ethics, and art of respiratory care. The Journal uses a web-based system called Manuscript Central for manuscript submission, peer review, and manuscript tracking. We ask that authors submit all manuscripts electronically using this system. Manuscripts submitted by mail or email will not be accepted. Manuscripts submitted by mail or email before the launch of Manuscript Central will not be found online. Detailed instructions are available on the site and the process should be self-explanatory.

No fees.

 

Chronic Respiratory Disease (Chron Respir Dis, IF: 1.519)

Chronic Respiratory Disease publishes original articles, reviews and correspondence on any subject relevant to chronic respiratory care. The journal particularly encourages papers of interdisciplinary authorship. The principal criteria for acceptance of material are originality and quality. All material submitted for publication is assumed to be submitted exclusively to Chronic Respiratory Disease unless the contrary is stated. Before acceptance, papers will be refereed and may be statistically assessed.

SAGE Choice Fees only: If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Choice subject to payment of a publication fee. The manuscript submission and peer reviewing procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. For further information, please visit SAGE Choice.

 

Heart & Lung - The Journal of Acute and Critical Care (Heart Lung, IF: 1.508)

Heart & Lung: The Journal of Acute and Critical Care invites original articles describing investigations, advances, or observations regarding the care of patients with acute and critical illness and patients with chronic cardiac or pulmonary disorders. Manuscripts should be submitted online at  http://ees.elsevier.com/hl. All articles are subject to expert peer review and are accepted for publication with the understanding they are contributed solely to Heart & Lung.

No fees.

 

Journal of Cardiopulmonary Rehabilitation and Prevention (J Cardiopulm Rehabil Prev, IF: 1.415)

Authors are invited to submit original investigations, scientific reviews, brief reports, and case reports in all areas relating to the prevention and management of cardiopulmonary disease. These areas include but are not limited to cardiac and/or pulmonary rehabilitation, primary and secondary prevention, epidemiology, and exercise testing and training.

No fees.

 

Canadian Respiratory Journal (Can Respir J, IF: 1.347)

The CANADIAN RESPIRATORY JOURNAL is the official journal of the Canadian Thoracic Society, which appoints the editors and determines editorial policy. The aim of the Journal is to be a respected international publication while serving as the major venue for Canadian respiratory medicine. It will consider for publication original reports of clinical and basic research relevant to respiratory medicine, as well as editorials, review articles and case reports (see page 3 of these instructions for details regarding case report format). Papers on health systems, ethics, medical history and political issues affecting practice, as well as letters to the editor are also welcomed. The Journal is pleased to accept articles in both English and French. Manuscripts are received with the understanding that they are submitted solely to the Canadian Respiratory Journal, and that none of the material contained in the manuscript has been published previously or is under consideration for publication elsewhere, with the exception of abstracts.

Submission Fee: Each submission must be accompanied by a nonrefundable fee of $50, with the exception of a corresponding author who is a CTS member, for whom the submission fee will be waived. There is no charge for black and white figures. However, authors will be charged for colour figures at the rate of $300 for the first figure and $100 for each subsequent figure.

 

Journal of Asthma (J Asthma, IF: 1.341)

Fees: There is a publication support fee for this, based on a charge of $850/€625/£550 per published page. This charge supports the ultra-swift processing of material and 20 downloads of the article via e-access tokens.

 

Heart, Lung and Circulation (Heart Lung Circ, IF: 1.330)

Heart, Lung and Circulation publishes articles integrating clinical and research activities in the fields of basic cardiovascular science, clinical cardiology and cardiac surgery, with a focus on emerging issues in cardiovascular disease. The Journal particularly invites submissions concerned with the issues of cardiovascular ageing, indigenous cardiovascular health, devices, and tissue repair and replacement. The Journal promotes multidisciplinary dialogue between cardiologists, cardiothoracic surgeons, cardio-pulmonary physicians and cardiovascular scientists and allied health professionals with an interest in cardiovascular diseases. The Journal accepts original articles, current reviews, brief communications, Clinical Spotlight papers (case reports) and letters to the Editor.

No fees.

 

Journal of Thoracic Imaging (J Thorac Imaging, IF: 1.207)

Journal of Thoracic Imaging (JTI) provides authoritative information on all aspects of the use of imaging techniques in the diagnosis of cardiac and pulmonary diseases. Original articles and analytical reviews published in this timely journal provide the very latest thinking of leading experts concerning the use of chest radiography, computed tomography, magnetic resonance imaging, positron emission tomography, ultrasound, and all other promising imaging techniques in cardiopulmonary radiology.

Color figure's fee only: There is an author's fee for the cost of color reproduction if an author chooses to submit color art with a manuscript. If the author does not want to cover the cost for color, the figure(s) will be reproduced in black and white at no charge.

 

Experimental Lung Research (Exp Lung Res, IF: 1.18)

OpenAccess fees only: Articles in Experimental Lung Research are eligible for non-commercial purchase via iOpenAccess. Electing this option allows the article to be made freely available online under a Creative Commons License. The iOpenAccess service requires registration with Rightslink, and payment of a one-time fee of $3250. Authors of accepted papers will have the opportunity to purchase iOpen Access at proofs stage. For further information about iOpenAccess, please contact the publisher. Please note: This option is separate from Informa Healthcare’s NIH/Wellcome Fund policy.

 

Cough (Cough, IF: 1.14)

No fees.

 

Jornal Brasileiro de Pneumologia (J Bras Pneumol, IF: 0.906) 

No fees.

 

The Thoracic and Cardiovascular Surgeon (Thorac Cardiovasc Surg, IF: 0.753)

The Thoracic and Cardiovascular Surgeon publishes original papers on topics in thoracic and cardiovascular surgery. Also featured are special reports, "how to do it" papers, articles on our surgical heritage, collective and current reviews, correspondence, and book reviews. If a manuscript is accepted for publication, certain conditions must be agreed to by all authors. These include statements regarding conflict of interests, scientific responsibility, exclusive publication, and assignment of copyright. No part of the published material may be reproduced elsewhere without written permission from the publisher.

No fees.

 

The Clinical Respiratory Journal (Clin Respir J, IF: 0.512)

Open access fee.

 

Journals without Impact Factor:

African Journal of Respiratory Medicine (Afr J Respir Med)

Alveolus

Allergy, Asthma and Clinical Immunology (Allergy Asthma Clin Immunol)

Breath (Breath)

Cardiopulmonary Physical Therapy Journal (Cardiopulm Phys Ther J)

Case Reports in Pulmonology (Case Rep Pulmonol)

Chest Disease Reports (Chest Dis Rep)

Chest Medicine On-Line (Chest Med Online)

Clinical Medicine : Circulatory, Respiratory and Pulmonary Medicine (Clin Med Circ Respirat Pulm Med)

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine (Clin Med Insights Circ Respir Pulm Med)

Clinical Pulmonary Medicine (Clin Pulm Med)

Current Respiratory Medicine Reviews (Curr Respir Med Rev)

European Respiratory Review (Eur Respir Rev)

Expert Review of Respiratory Medicine (Expert Rev Respir Med)

Indian Journal of Allergy Asthma and Immunology (Indian J Allergy Asthma Immunol)

International Journal of Chronic Obstructive Pulmonary Disease (Int J Chron Obstruct Pulmon Dis)

International Journal of Respiratory Care (Int J Respir Care)

Iranian Journal of Allergy, Asthma and Immunology (Iran J Allergy Asthma Immunol)

ISRN Pulmonology (ISRN Pulmonol)

Journal of Asthma and Allergy (J Asthma Allergy)

Journal of Bronchology & Interventional Pulmonology (J Bronchology Interv Pulmonol)

Journal of Chronic Obstructive Pulmonary Disease (J Chron Obstruct Pulmon Dis)

Journal of Pulmonary & Respiratory Medicine (J Pulm Respir Med)

Kokyu to Junkan - Respiration & circulation (Kokyu To Junkan)

Lung Cancer: Targets and Therapy (Lung Cancer Targ Ther

Lung India (Lung India)

Minerva Pneumologica (Minerva Pneumol)

Monaldi Archives for Chest Diseases (Monaldi Arch Chest Dis)

Pediatric Allergy and Respiratory Disease (Pediatr Allergy Respir Dis)

Pediatric Allergy, Immunology, and Pulmonology (Pediatr Allergy Immunol Pulmonol)

Pediatric Asthma, Allergy and Immunology (Pediatr Asthma Allergy Immunol)

Pneumon (Pneumon)

Proceedings of the American Thoracic Society (Proc Am Thorac Soc)

Progress in Respiratory Research (Prog Respir Res)

Pulmonary Circulation (Pulm Circ)

Pulmonary Medicine (Pulm Med)

PVRI Review (PVRI Rev)

Respiratory Medicine CME (Respir Med CME)

Southwest Journal of Pulmonary & Critical Care (Southwest J Pulm Crit Care)

Tanaffos : Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis (Tanaffos)

The Annals of Respiratory Medicine (Ann Respir Med)

The Indian Journal of Chest Diseases and Allied Sciences (Indian J Chest Dis Allied Sci)

The Internet Journal of Asthma, Allergy and Immunology (Internet J Asthma Allergy Immunol)

The Internet Journal of Pulmonary Medicine (Internet J Pulmonol Med)

The Journal of Respiratory Diseases (J Respir Dis)

The Journal of Respiratory Diseases (J Respir Dis)

The Journal of the Japanese Respiratory Society (Nihon Kokyuki Gakkai Zasshi)

The Open Allergy Journal  (Open Allergy J)

The Open Respiratory Medicine Journal (Open Respir Med J)

Therapeutic Advances in Respiratory Disease (Ther Adv Respir Dis)

Thoracic Cancer (Thorac Canc)

Thoracic Surgery Clinics (Thorac Surg Clin)

Tuberculosis and Respiratory Diseases (Tuberc Respir Dis)

Tuberculosis Research and Treatment (Tuberc Res Treat)

Year Book of Pulmonary Disease (Year B Pulm Dis)